Generic Name:
ocrelizumab
Project Status:
Complete
Therapeutic Area:
Primary progressive multiple sclerosis
Manufacturer:
Hoffman-La Roche Limited
Call for patient/clinician input open:
Brand Name:
Ocrevus
Project Line:
Reimbursement Review
Project Number:
SR0542-000
Call for patient/clinician input closed:
Details
Submission Type:
Initial
Fee Schedule:
Schedule B
Indications:
Primary progressive multiple sclerosis
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: